Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Dec '24 Dec '25
P/E ratio
0.00 0.00
Altman Z-Score
— 2.53
P/S ratio
0.05 2.62
Altman Z″-Score (non-manufacturers)
(1.53) 7.68
P/FCF ratio
0.00 0.00
P/Operating CF
(0.36) (14.12)
Beneish M-Score
— (2.42)
P/B ratio
0.00 0.88
Price to Tangible BV
0.00 0.88
EV/Sales
(0.63) 0.31
EV/EBITDA
1.45 0.00
EV/Operating CF
1.19 (0.51)
EV/FCF
0.98 (0.41)
Quick Ratio
2.64 9.34
Current Ratio
4.59 11.07
Net Debt/EBITDA
0.03 4.79
Debt/Assets
34.03% 8.78%
Debt/Equity
0.74 0.11
Asset Turnover
0.00 0.44
Operating CF/Net income
0.91 0.71
Capex/Depreciation
(1.60) (2.14)
Interest Coverage
(11.13) (375.67)
ROE
0.00% (93.80%)
ROA
0.00% (37.90%)
ROIC
(47.22%) (52.42%)
Return on Tangible Assets
(44.67%) (25.95%)
Average Days of Receivables
59.12 63.78
Research and Development Expense of Revenue
14.20% 16.34%
Selling, General and Administrative Expense of Revenue
109.11% 115.75%
Intangible Assets out of Total Assets
0.01 0.00
Share Based Compensation of Revenue
2.38% 2.10%
Graham Net Nets
22.67 1.03
Graham Number
0.00 0.00
Earnings Yield
(2,386.39%) (1,529.23%)
Free Cash Flow Yield
(1,356.23%) (29.04%)
Revenue per Share
490.28 5.46
Operating CF per Share
(219.27) (3.30)
Capex per Share
(62.25) (0.85)
Free Cash Flow per Share
(281.52) (4.15)
Cash per Share
233.24 14.33
Shareholders Equity per Share
306.67 16.23
Interest Debt per Share
0.00 0.00
Book value per Share
306.67 16.23
Free Cash Flow
(18.16) (36.02)
Working Capital
27.48 142.97
Capital Expenditures
(4.01) (7.41)
Net Current Asset Value
11.83 128.01
EV/EBIT
1.28 0.00
Capex to Sales
0.13 0.16
Price to Operating Income
0.00 0.00
Other line items
Depreciation/Fixed assets
0.33 0.28
Cash ROIC
(36.70%) (12.87%)
Accounts Receivable Turnover
0.00 7.07
Accounts Payable Turnover
0.00 1.62
Inventory Turnover
0.00 0.63
Average Days of Payables
243.60 291.41
Days of Inventory on Hand
699.47 709.02
Average Receivables
— 6.70
Average Payables
— 6.87
Average Inventory
— 17.77
Average Assets
— 106.49
Average Common Equity
— 43.03

Fold the line items

Columns are period end dates